Gene: VPS9D1
Official Full Name: VPS9 domain containing 1provided by HGNC
Gene Summary: Enables identical protein binding activity. Predicted to be involved in proton motive force-driven ATP synthesis. Predicted to be active in cytosol and endocytic vesicle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33047 | VPS9D1 Knockout cell line (HeLa) | Human | VPS9D1 | 1:3~1:6 | Negative | Online Inquiry |
KO33048 | VPS9D1 Knockout cell line (HCT 116) | Human | VPS9D1 | 1:2~1:4 | Negative | Online Inquiry |
KO33049 | VPS9D1 Knockout cell line (HEK293) | Human | VPS9D1 | 1:3~1:6 | Negative | Online Inquiry |
KO33050 | VPS9D1 Knockout cell line (A549) | Human | VPS9D1 | 1:3~1:4 | Negative | Online Inquiry |
VPS9D1 Gene Knockout Cell Lines are specialized cellular models designed specifically for the study of vesicular trafficking, a crucial process in cellular homeostasis and signaling. These cell lines are created using advanced CRISPR/Cas9 gene editing technology to eliminate the expression of the VPS9D1 gene, which encodes a protein involved in the regulation of endosomal and lysosomal pathways. By knocking out VPS9D1, researchers can investigate the molecular mechanisms underlying various cellular processes, such as cargo sorting, membrane recycling, and intracellular signaling.
The primary function of the VPS9D1 knockout cell lines is to provide a standardized platform for examining the effects of VPS9D1 deficiency on endosomal dynamics and to unveil the impact of disrupted trafficking pathways on disease states, such as neurodegenerative disorders and cancer. Through rigorous analysis of cellular behavior, researchers can elucidate the role of VPS9D1 in critical biogenic pathways and the potential for therapeutic targeting in related pathologies.
The scientific importance of VPS9D1 knockout cell lines is underscored by their applications in both basic research and clinical settings. These models enable researchers to explore fundamental questions regarding cellular homeostasis and disease mechanisms, while also facilitating the development of targeted therapies. They serve as valuable tools for drug screening and biological assays, making them indispensable for laboratories focused on molecular biology and therapeutic development.
Unlike alternatives that may focus on incomplete gene silencing or lack specificity, VPS9D1 knockout cell lines offer a complete gene deletion, ensuring that experimental results are both reliable and reproducible. Their high degree of specificity allows researchers to draw clear conclusions regarding the role of VPS9D1 without the confounding effects seen in partial knockdown models.
For researchers and clinicians seeking to unlock new pathways in cell biology, VPS9D1 Gene Knockout Cell Lines present a pivotal resource. Their robust design, coupled with our company’s commitment to providing high-quality biological products, empowers scientists to push the boundaries of research while fostering innovation in therapeutic solutions. Our expertise in advanced gene editing technologies ensures that we deliver products of unmatched quality, reliability, and functionality.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.